Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Amgen Inc (AMGN)  
$318.15 9.99 (3.24%) as of 4:30 Mon 6/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 585,690,000
Market Cap: 186.34(B)
Last Volume: 3,388,705 Avg Vol: 2,717,833
52 Week Range: $218.65 - $324.56
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 100     S&P 500
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  499
Guru Rank Value     : 3
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 2,117 2,117 23,771 31,503
Total Sell Value $662,802 $662,802 $6,471,520 $8,438,219
Total People Sold 1 1 3 6
Total Sell Transactions 1 1 4 8
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 2206
  Page 31 of 89  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baltimore David Director   –       •      –    2016-04-29 4 S $157.21 $520,684 D/D (3,312) 32,350     -
   Patton Cynthia M SVP & CCO   •       •      –    2016-04-27 4 D $162.85 $37,456 D/D (230) 20,878     -
   Mcnamee Brian M EVP   •       •      –    2016-04-27 4 D $162.85 $133,211 D/D (818) 88,408     -
   Hooper Anthony C EVP, Global Commercial Ops.   •       •      –    2016-04-27 4 D $162.85 $270,168 D/D (1,659) 184,196     -
   Harper Sean E EVP, Research & Development   •       •      –    2016-04-27 4 D $162.85 $270,168 D/D (1,659) 64,123     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2016-04-27 4 D $162.85 $653,354 D/D (4,012) 340,875     -
   Balachandran Madhavan EVP, Operations   •       •      –    2016-04-27 4 GA $0.00 $0 I/I 462 85,996     -
   Balachandran Madhavan EVP, Operations   •       •      –    2016-04-27 4 GD $0.00 $0 D/D 462 19,516     -
   Balachandran Madhavan EVP, Operations   •       •      –    2016-04-27 4 D $162.85 $75,237 D/D (462) 19,978     -
   Tross Stuart A SVP, Human Resources   •       •      –    2016-04-27 4 D $162.85 $41,364 D/D (254) 23,625     -
   Piacquad David SVP, Business Development   •       •      –    2016-04-27 4 D $162.85 $47,064 D/D (289) 31,336     -
   Tross Stuart A SVP, Human Resources   •       •      –    2016-04-26 4 D $163.46 $29,586 D/D (181) 23,879     -
   Piacquad David SVP, Business Development   •       •      –    2016-04-26 4 D $163.46 $25,173 D/D (154) 31,635     -
   Such Annette Louise VP, Finance and CAO   •       •      –    2016-04-26 4 D $163.46 $6,702 D/D (41) 9,839     -
   Piacquad David SVP, Business Development   •       •      –    2016-04-25 4 D $163.19 $34,270 D/D (210) 31,789     -
   Such Annette Louise VP, Finance and CAO   •       •      –    2016-04-25 4 D $163.19 $6,364 D/D (39) 9,880     -
   Baltimore David Director   •       •      –    2016-03-30 4 D $149.49 $252,339 D/D (1,688) 35,662     -
   Baltimore David Director   •       •      –    2016-03-30 4 OE $50.44 $252,200 D/D 5,000 37,350     -
   Balachandran Madhavan EVP, Operations   •       •      –    2016-03-25 4 GA $0.00 $0 I/I 21,796 85,534     -
   Balachandran Madhavan EVP, Operations   •       •      –    2016-03-25 4 GD $0.00 $0 D/D 21,796 20,440     -
   Balachandran Madhavan EVP, Operations   •       •      –    2016-03-25 4 D $149.24 $3,549,673 D/D (23,785) 42,236     -
   Hooper Anthony C EVP, Global Commercial Ops.   •       •      –    2016-03-25 4 D $149.24 $3,549,673 D/D (23,785) 185,855     -
   Tross Stuart A SVP, Human Resources   •       •      –    2016-03-25 4 D $149.24 $403,396 D/D (2,703) 24,060     -
   Such Annette Louise VP, Finance and CAO   •       •      –    2016-03-25 4 D $149.24 $108,796 D/D (729) 9,919     -
   Piacquad David SVP, Business Development   •       •      –    2016-03-25 4 D $149.24 $344,297 D/D (2,307) 31,999     -
  2206 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 31 of 89
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us